Skip to main content

HSBC HOLDINGS PLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 873630 LONDON, X0

Position in APLS

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$0
+$0 QoQ
Shares Held
5,944
-60.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 5,944
2025-09-30 15,025
2025-06-30 57,898
2025-03-31 24,999
2024-12-31 127,828
2024-09-30 118,487
2024-06-30 34,924
2024-03-31 98,550
2023-09-30 50,544
2023-03-31 17,530
2022-06-30 10,887
2022-03-31 9,891
2021-12-31 4,601
2021-06-30 3,701
2020-06-30 7,580